BIOMEDICAL CERAMICS · MATERIALS R&D

A material
foundation for
bone repair.

Developing calcium polyphosphate materials for implant coatings and bone-graft applications in orthopedics and dentistry.

From material chemistry to implant interfaces and bone repair.

01 / COMPANY

About Us

Progress starts
with the material.

Ossiphora Biomed is developing a Canadian biomedical ceramics company around calcium polyphosphate, or CPP.

Our research began with CPP coatings on titanium-alloy implants. Today, our focus spans electrodeposition, CPP material development, and mineral-based bone-graft research.

We connect materials science with manufacturing research, working toward reproducible materials that partners can evaluate for their own applications.

Materials scienceImplant interfacesApplication-led development

Our Team

Portrait of Zhengyanyan Leo Li

CO-FOUNDER · CEO

Zhengyanyan Leo Li M.Eng.

Technology development and commercialization

PhD Candidate
University of Toronto

Zhengyanyan Leo Li is a PhD candidate at the University of Toronto, where he earned his bachelor’s and master’s degrees in materials engineering with focuses on biomedical engineering and advanced manufacturing. His research includes electrodeposition and bioceramics for orthopedic implants. As co-founder and CEO of Ossiphora Biomed, he leads technology development and commercialization.

Portrait of Prof. Yu Zou

CO-FOUNDER · ADVISOR

Prof. Yu Zou Ph.D.

Materials science and additive manufacturing

Associate Professor · Dean’s Spark Professor
Department of Materials Science & Engineering
University of Toronto

Prof. Yu Zou is an Associate Professor, Dean’s Spark Professor, and Canada Research Chair in Materials and Manufacturing for Extreme Environments at the University of Toronto. He leads the Laboratory for Extreme Mechanics & Additive Manufacturing, where his group studies advanced materials, multiscale mechanics, metal 3D printing, and machine learning. As an Ossiphora Biomed co-founder and advisor, he contributes expertise in materials science and additive manufacturing.

Portrait of Prof. Marc Grynpas

CO-FOUNDER · ADVISOR

Prof. Marc Grynpas Ph.D.

Biomedical materials and clinical research

Professor Emeritus
Department of Laboratory Medicine and Pathobiology
University of Toronto

Prof. Marc Grynpas is a Professor Emeritus in the University of Toronto’s Department of Laboratory Medicine and Pathobiology, with an affiliation in the Institute of Biomedical Engineering. His research examines bone mineral and matrix, skeletal tissue engineering, and the factors that affect bone quality and fragility. As an Ossiphora Biomed co-founder and advisor, he contributes expertise in biomedical materials and bone research.

02 / TECHNOLOGY

One chemistry.
Multiple possibilities.

Our platform centers on synthetically produced, non-animal-sourced CPP, a chain-structured calcium phosphate ceramic. This approach avoids animal-derived raw materials and gives us control over composition and processing, supporting reproducible material development.

01 / MATERIAL DEVELOPMENT

CPP powders

THE MATERIAL PLATFORM

Calcium polyphosphate[Ca(PO3)2]n

Material details

Material development guided by phase composition, particle characteristics, and degradation behavior.

CompositionProcessingPerformance

Working toward specification-controlled powders for research and future medical-device supply chains, with an emphasis on reproducibility and material characterization.

02 / SURFACES

Implant coatings

Research focus

Electrodeposition, coating integrity, adhesion, and material behavior under laboratory evaluation.

Our patent-pending electrodeposition approach to CPP coatings on titanium alloys combines a low-cost process with high coating strength. It underpins our research into material–implant interfaces.

PCT/CA2025/05131
Schematic of CPP electrodeposition using a platinum-coated titanium anode and a Ti-6Al-4V cathode in a stirred calcium chloride, isopropyl alcohol, and deionized water suspension.

Zhengyanyan Leo Li, Barmaan Shafiee, Nuo Qu, Ruitian Chen, Mingyu Xie, Jingjie Wei, Marc Grynpas, Yu Zou. Electrodeposition of Calcium Polyphosphate on Ti-6Al-4V Substrates for Rapid Osseointegration in Orthopedic Applications. ACS Applied Bio Materials, 2026, 9 (13), 5823–5836. https://doi.org/10.1021/acsabm.6c00504

03 / STRUCTURES

Bone-graft development

Research focus

Degradation behavior, mechanical performance, and biological response for defined applications.

Investigating CPP as a mineral-based bone-graft platform for orthopedics and dentistry, with the aim of reducing reliance on autografts and animal-sourced bone grafts.

Current stage: research & development

We are developing materials and evaluating intended applications. Commercial supply and clinical use are future objectives subject to product qualification and appropriate authorization.

03 / PARTNERSHIPS

Build the next
step with us.

Our intended business-to-business model brings material development closer to the needs of device manufacturers, bone-graft developers, and research collaborators.

Contact: zhengyanyan.li@mail.utoronto.ca

01

Research collaboration

Connect material characterization with application-specific testing.

02

Manufacturing partnerships

Shape specifications, processing requirements, and qualification priorities.

03

Investment & commercialization

Support the transition from laboratory development toward a scalable materials business.

04 / OUR NETWORK

Our Partners

We acknowledge funding support from Natural Sciences and Engineering Research Council of Canada (NSERC) Idea to Innovation (I2I) grant, University of Toronto Connaught Innovation Award, and BioHubNet VentureConnect grant.
Nous remercions le Conseil de recherches en sciences naturelles et en génie du Canada (CRSNG), dans le cadre de la subvention Idea to Innovation (I2I), le programme Connaught Innovation Award de l’Université de Toronto et la subvention VentureConnect de BioHubNet pour leur soutien financier à notre recherche.